[1]程涛, 马程远, 尹亚楠, 等. 依达拉奉减轻慢性阻塞性肺疾病大鼠氧化应激和炎性反应[J]. 基础医学与临床, 2021, 41:1457-1462. [2]Pulito C, Strano S, Blandino G. Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers[J]. Ann Transl Med, 2020, 8:612-615. [3]杨宁, 王大伟, 赵雅彬, 等. 双氢青蒿素减轻失血性休克大鼠肺损伤[J]. 基础医学与临床, 2021, 41:1266-1271. [4]Yang DX, Qiu J, Zhou HH, et al. Dihydroartemisinin alleviates oxidative stress in bleomycin-induced pulmonary fibrosis[J]. Life Sci, 2018, 205:176-183. [5]Huang H, Huang X, Zeng K, et al. Interleukin-6 is a strong predictor of the frequency of COPD exacerbation within 1 year[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16:2945-2951. [6]Chen D, Li Z, Bao P, et al. Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflamma-tion[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865:1253-1264. [7]Sun Y, Lu X, Li H, et al. Dihydroartemisinin inhibits IL-6-induced epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway[J]. J Int Med Res, 2021, 49:3000605211009494. doi: 10.1177/03000605211009494. [8]Zhu H, Ji W. Dihydroartemisinin ameliorated ovalbumin-induced asthma in mice via regulation of miR-183C[J]. Med Sci Monit, 2019, 25:3804-3814. [9]邓玉英, 郝月琴, 孙文欣, 等. 孟鲁司特对慢性阻塞性肺疾病大鼠气道炎症和重塑的影响及其机制[J]. 临床肺科杂志, 2018, 23:437-442. [10]Yang Y, Huang L, Tian C, et al. Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2021, 21:371-381. [11]Liu X, Lu J, Liao Y, et al. Dihydroartemisinin attenuates lipopolysaccharide-induced acute kidney injury by inhibit-ing inflammation and oxidative stress[J]. Biomed Pharmacother, 2019, 117:109070. doi: 10.1016/j.biopha.2019.109070. [12]Serrano C, Galán S, Rubio JF, et al. Compartmentalized response of IL-6/STAT3 signaling in the colonic mucosa mediates colitis development[J]. J Immunol, 2019, 202:1239-1249. [13]Liang T, Chen T, Qiu J, et al. Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway[J]. Cell Death Dis, 2021, 12:886-898. |